2.5 mg semaglutide equivalent to tirzepatide Subcutaneously administered vs for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Switching from Semaglutide to Tirzepatide:

10.1073/pnas.0806720106 121

Additionally, some individuals have experienced a reduction in other addictive tendencies, such as nail-biting and compulsive shopping (Zhang 2023)

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved these medications for glycaemic control and weight management, not as primary anti-inflammatory agents

Nearly five in every 1,000 users of semaglutide drugs developed pancreatitis, compared to one of every 1,000 users of bupropion-naltrexone, the active ingredients in the weight-loss drug Contrave, according to a report in the JAMA medical journal

[1] [17] Importantly, when used as monotherapy, these medications have a low risk of hypoglycemia